Harnessing retinal phagocytes to combat pathological neovascularization in ischemic retinopathies?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2013
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Harnessing retinal phagocytes to combat pathological neovascularization in ischemic retinopathies? ; volume:474 ; number:6 ; day:7 ; month:5 ; year:2022 ; pages:575-590 ; date:6.2022
Pflügers Archiv ; 474, Heft 6 (7.5.2022), 575-590, 6.2022
- Urheber
-
Klotzsche-von Ameln, Anne
Sprott, David
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00424-022-02695-7
- URN
-
urn:nbn:de:101:1-2022072119023390951501
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Klotzsche-von Ameln, Anne
- Sprott, David
- SpringerLink (Online service)
Ähnliche Objekte (12)
Harnessing retinal phagocytes to combat pathological neovascularization in ischemic retinopathies?
Interferon‐beta signaling in retinal mononuclear phagocytes attenuates pathological neovascularization
Downregulation of PIK3IP1 in retinal microglia promotes retinal pathological neovascularization via PI3K-AKT pathway activation
Microglia in pathological neovascularization in the retina
Transcriptional comparison of human and murine retinal neovascularization
Harnessing RKIP to combat heart disease and cancer
Neuronal Bmal1 regulates retinal angiogenesis and neovascularization in mice
Harnessing PROTAC technology to combat stress hormone receptor activation
Gut microbiota influences pathological angiogenesis in obesity‐driven choroidal neovascularization
NCK-dependent pericyte migration promotes pathological neovascularization in ischemic retinopathy
Harnessing host innate immunity may combat acquired resistance to BRAFi
Harnessing immunomodulation to combat sarcopenia: current insights and possible approaches
Harnessing retinal phagocytes to combat pathological neovascularization in ischemic retinopathies?
Interferon‐beta signaling in retinal mononuclear phagocytes attenuates pathological neovascularization
Downregulation of PIK3IP1 in retinal microglia promotes retinal pathological neovascularization via PI3K-AKT pathway activation
Microglia in pathological neovascularization in the retina
Transcriptional comparison of human and murine retinal neovascularization
Harnessing RKIP to combat heart disease and cancer
Neuronal Bmal1 regulates retinal angiogenesis and neovascularization in mice
Harnessing PROTAC technology to combat stress hormone receptor activation
Gut microbiota influences pathological angiogenesis in obesity‐driven choroidal neovascularization
NCK-dependent pericyte migration promotes pathological neovascularization in ischemic retinopathy
Harnessing host innate immunity may combat acquired resistance to BRAFi
Harnessing immunomodulation to combat sarcopenia: current insights and possible approaches
Harnessing retinal phagocytes to combat pathological neovascularization in ischemic retinopathies?
Interferon‐beta signaling in retinal mononuclear phagocytes attenuates pathological neovascularization
Downregulation of PIK3IP1 in retinal microglia promotes retinal pathological neovascularization via PI3K-AKT pathway activation
Microglia in pathological neovascularization in the retina
Transcriptional comparison of human and murine retinal neovascularization
Harnessing RKIP to combat heart disease and cancer
Neuronal Bmal1 regulates retinal angiogenesis and neovascularization in mice
Harnessing PROTAC technology to combat stress hormone receptor activation
Gut microbiota influences pathological angiogenesis in obesity‐driven choroidal neovascularization
NCK-dependent pericyte migration promotes pathological neovascularization in ischemic retinopathy
Harnessing host innate immunity may combat acquired resistance to BRAFi